Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
Clinical trial NCT00790400 · COMPLETED
Trial details
- NCT number
- NCT00790400
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2011-06-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.